Reddy, R., Muir, A., Naggie, S., Lawitz, E., Gane, E., Conway, B., … Mangia, A. (2020). Non-invasive tests of fibrosis and risk of liver-related complications: observations following successful sofosbuvir-based treatment in patients with HCV cirrhosis. In JOURNAL OF HEPATOLOGY (Vol. 73, pp. S622–S622).

Reddy, Rajender, Andrew Muir, Susanna Naggie, Eric Lawitz, Edward Gane, Brian Conway, Peter Ruane, et al. “Non-invasive tests of fibrosis and risk of liver-related complications: observations following successful sofosbuvir-based treatment in patients with HCV cirrhosis.” In JOURNAL OF HEPATOLOGY, 73:S622–S622, 2020.

Reddy R, Muir A, Naggie S, Lawitz E, Gane E, Conway B, et al. Non-invasive tests of fibrosis and risk of liver-related complications: observations following successful sofosbuvir-based treatment in patients with HCV cirrhosis. In: JOURNAL OF HEPATOLOGY. 2020. p. S622–S622.

Reddy, Rajender, et al. “Non-invasive tests of fibrosis and risk of liver-related complications: observations following successful sofosbuvir-based treatment in patients with HCV cirrhosis.” JOURNAL OF HEPATOLOGY, vol. 73, 2020, pp. S622–S622.

Reddy R, Muir A, Naggie S, Lawitz E, Gane E, Conway B, Ruane P, Younes ZH, Chen F, Camargo M, Gaggar A, Myers R, Chokkalingam A, Leggett B, Calleja Panero JL, Agarwal K, Jacobson I, Mangia A. Non-invasive tests of fibrosis and risk of liver-related complications: observations following successful sofosbuvir-based treatment in patients with HCV cirrhosis. JOURNAL OF HEPATOLOGY. 2020. p. S622–S622.